CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
Irvine, CA – November 4, 2020 - Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a Category level III Current Procedural Terminology (CPT®) reimbursement code for “transperineal focal laser ablation of malignant prostate tissue with ultrasound guidance.” The new code is expected to be formally finalized and active from July 1, 2021. The CPT terminology is the most widely accepted medical nomenclature used across the U.S. to report